ArticleClinical case reports2016
Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.
Article in Clinical case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.
- Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports.Annals of hematology · 2024Pooled it
- Biochemical deciphering of an Atypical methemoglobinemia.Practical laboratory medicine · 2026Article
- Glucose-6-phosphate dehydrogenase deficiency induced hemolytic anemia and methemoglobinemia: a case report in a 7 -year-old female patient.Italian journal of pediatrics · 2025Article
- Treatment of acute kidney injury in cancer patients.Clinical kidney journal · 2022Review
- Glucose-6-phosphate dehydrogenase deficiency presenting with rhabdomyolysis in a patient with coronavirus disease 2019 pneumonia: a case report.Journal of medical case reports · 2022Article
- Acute kidney injury in cancer patients.Clinical and experimental nephrology · 2022Review
- Rasburicase-Induced Methemoglobinemia.Cureus · 2021Article
- Low Hemoglobin Saturation in the Setting of Hyperuricemia.Annals of the American Thoracic Society · 2019Article
- Acute kidney injury in the patient with cancer.Kidney research and clinical practice · 2019Review
- [Establishment of a stable HEK293T cell line with c.392G>T (p.131G>V) mutation site knockout inNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019Article
- Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS.Respiratory medicine case reports · 2019Article
- Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm.Clinical case reports · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rasburicase for the treatment of tumor lysis syndrome has been associated with hemolytic anemia and methemoglobinemia, usually in patients with G6PD deficiency. Risks and benefits should be considered prior to use of rasburicase in at-risk patients. Methylene blue will worsen the hemolytic anemia in G6PD deficiency and should be avoided.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.